POLICY BRIEFINGS


FDA Fast Tracks Ebola Drug


The Food and Drug Administration (FDA) has decided to grant fast track approval to ZMapp, an experimental drug that was given to the first American treated for Ebola in the United States. The drug was first administered under emergency use authorization for patients in Africa, the United States, and Western Europe. The first clinical trial of ZMapp took place in Liberia and the United States. The medicine works by preventing the virus from entering and infecting new cells. It takes six months to produce and supply is still extremely limited.


Upcoming Congressional Meetings and Hearings


His Holiness Pope Francis will make history as the first Pope to ever address a joint meeting of Congress on September 24, 2015 at 10:00 a.m.

Senate Health, Education, Labor and Pensions (HELP) Committee: hearing on health information technology; time and place tba, Oct 1, as announced at the committee’s Sept. 16 HIT hearing

House Veterans’ Affairs Committee: hearing titled “A Call for System-Wide Change: Evaluating the Independent Assessment of the Veterans Health Administration;” 10:30 a.m., 334 Cannon Bldg., Oct. 7


Health Legislation Recently Introduced


H.R. 3498 (introduced by Rep. Harris): A bill to amend title 18, United States Code, to prohibit human cloning; to the Committee on the Judiciary. (Sept. 11)

H. Res. 419 (introduced by Rep. Lowey for herself and Rep. Chrenshaw): A resolution recognizing the importance of frontline health workers toward accelerating progress on global health and saving the lives of women and children, and for other purposes; to the Committee on Foreign Affairs. (Sept. 15)

H.R. 3513 (introduced by Rep. Cummings for himself, Rep. Ellison, Rep. Norton, and Rep. Sarbanes): A bill to ensure greater affordability of prescription drugs; to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (Sept. 16)

H.R. 3520 (introduced by Rep. Brady of Texas for himself and Rep. Capps): A bill to amend the Public Health Service Act to establish an interagency coordinating committee on pulmonary hypertension, and for other purposes; to the Committee on Energy and Commerce. (Sept. 16)

H.R. 3525 (introduced by Rep. Engel): A bill to direct the Secretary of Energy to establish a pilot program to award grants and loan guarantees to hospitals to carry out projects for the purpose of reducing energy costs and increasing resilience to improve security; to the Committee on Energy and Commerce. (Sept. 16)

H.R. 3537 (introduced by Rep. Dent for himself and 16 others): A bill to amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated, and for other purposes; to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (Sept. 17)

H.R. 3539 (introduced by Rep. Boustany for himself, Rep. Thompson of California, Rep. Paulsen, Rep. Shimkus, and Rep. Gene Green of Texas): A bill to amend the Internal Revenue Code of 1986 to allow a credit against tax for clinical testing expenses for qualified infectious disease drugs and rapid diagnostic tests; to the Committee on Ways and Means. (Sept. 17)



December 31, 1969: | Page 1 Page 2 Page 3 Page 4

SERVICES




BRIEFING ARCHIVE


 -  2018